Ontrak (OTRK) 10-K 7 Mar 18 2017 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 02, 2018	Jun. 30, 2017
Document Information [Line Items]
Entity Registrant Name	CATASYS, INC.
Entity Central Index Key	1,136,174
Trading Symbol	cats
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		15,913,171
Entity Public Float			$ 21,329,027
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)		Dec. 31, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents		$ 4,779,000	$ 851,000
Receivables, net of allowance for doubtful accounts of $476 and $0, respectively		511,000	1,052,000
Prepaids and other current assets		366,000	420,000
Total current assets		5,656,000	2,323,000
Long-term assets
Property and equipment, net of accumulated depreciation of $1,542 and $1,620, respectively		612,000	410,000
Deposits and other assets		336,000	371,000
Total Assets		6,604,000	3,104,000
Current liabilities
Accounts payable		980,000	870,000
Accrued compensation and benefits		1,177,000	2,089,000
Deferred revenue		2,914,000	1,525,000
Other accrued liabilities		578,000	575,000
Short term debt, related party, net of discount of $0 and $216, respectively			9,796,000
Short term derivative liability			8,122,000
Total current liabilities		5,649,000	22,977,000
Long-term liabilities
Deferred rent and other long-term liabilities		25,000	117,000
Capital leases		2,000	31,000
Warrant liabilities		30,000	5,307,000
Total Liabilities		5,706,000	28,432,000
Commitments and contingencies (note 8)
Stockholders' equity/(deficit)
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding		0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 15,889,171 and 9,214,743 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively	[1]	2,000	1,000
Additional paid-in-capital		294,220,000	254,390,000
Accumulated deficit		(293,324,000)	(279,719,000)
Total Stockholders' equity/(deficit)		898,000	(25,328,000)
Total Liabilities and Stockholders' Equity/(Deficit)		$ 6,604,000	$ 3,104,000
[1]	The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares
Receivables, allowance for doubtful accounts | $	$ 476	$ 0
Property and equipment, accumulated dereciation | $	1,542	1,620
Short term debt, related party, discount | $	$ 0	$ 216
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	15,889,171	9,214,743
Common stock, shares outstanding (in shares)	15,889,171	9,214,743
Reverse Stock Split [Member]
Reverse stock split	6

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Revenues:
Healthcare services revenues		$ 7,717	$ 7,075
Operating expenses
Cost of healthcare services		6,391	4,670
General and administrative		11,811	8,838
Depreciation and amortization		246	141
Total operating expenses		18,448	13,649
Loss from operations		(10,731)	(6,574)
Other income		132	106
Interest expense		(3,409)	(5,354)
Loss on conversion of note		(1,356)
Loss on issuance of common stock		(145)
Loss on debt extinguishment			(2,424)
Change in fair value of warrant liability		1,778	2,093
Change in fair value of derivative liability		132	(5,774)
Loss from operations before provision for income taxes		(13,599)	(17,927)
Provision for income taxes		6	9
Net loss		$ (13,605)	$ (17,936)
Basic and diluted net loss per share: (in dollars per share)		$ (0.99)	$ (1.95)
Basic weighted number of shares outstanding (in shares)	[1]	13,751	9,179
[1]	The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017.

Consolidated Statements of Ope5

Consolidated Statements of Operations (Parentheticals)	Apr. 25, 2017	Dec. 31, 2017
Reverse Stock Split [Member]
Reverse stock split	6	6

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)		Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2015		9,167,960
Balance at Dec. 31, 2015		$ 1,000	$ 253,058,000	$ (261,783,000)	$ (8,724,000)
Warrants Exercised (in shares)		7,616
Warrants Exercised			46,000		46,000
Common stock issued for outside services (in shares)		39,167
Common stock issued for outside services		$ 235,000	235,000		235,000
Extinguishment of Debt			354,000		354,000
Share-based Compensation Expense			697,000		697,000
Net loss				(17,936,000)	$ (17,936,000)
Balance (in shares) at Dec. 31, 2016		9,214,743			9,214,743
Balance at Dec. 31, 2016		$ 1,000	254,390,000	(279,719,000)	$ (25,328,000)
Common stock issued for outside services (in shares)		28,985
Common stock issued for outside services		$ 181,000	181,000		181,000
Share-based Compensation Expense			$ 465,000		465,000
Net loss				(13,605,000)	$ (13,605,000)
Conversion of debentures		$ 2,982,994
Conversion of debentures (in shares)			16,509,000		16,509,000
Warrants issued for services			$ 252,000		$ 252,000
Deferred salary paid in common stock (in shares)		233,734
Deferred salary paid in common stock			1,204,000		1,204,000
Public offering (in shares)		3,428,750
Public offering		$ 1,000	16,457,000		16,458,000
1:6 reverse stock split (in shares)	[1]	(35)
1:6 reverse stock split	[1]		63,000		63,000
Warrant liability write-off			6,879,000		6,879,000
Transaction Costs			(2,180,000)		$ (2,180,000)
Balance (in shares) at Dec. 31, 2017		15,889,171			15,889,171
Balance at Dec. 31, 2017		$ 2,000	$ 294,220,000	$ (293,324,000)	$ 898,000
[1]	The financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017

Consolidated Statements of Sto7

Consolidated Statements of Stockholders' Equity (Deficit) (Parentheticals)	Apr. 25, 2017	Dec. 31, 2017
Reverse Stock Split [Member]
Reverse stock split	6	6

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Operating activities:
Net loss	$ (13,605)	$ (17,936)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	246	141
Amortization of debt discount and issuance costs included in interest expense	3,082	4,651
Loss on debt extinguishment		2,424
Provision for doubtful accounts	590	47
Deferred rent	(81)	(70)
Share-based compensation expense	465	697
Loss on conversion of convertible note	1,356
Loss on issuance of common stock, related party	145
Fair value adjustment on warrant liability	(1,778)	(2,093)
Fair value adjustment on derivative liability	(132)	5,774
Changes in current assets and liabilities:
Receivables	(49)	(509)
Prepaids and other current assets	54	155
Deferred revenue	1,389	77
Accounts payable and other accrued liabilities	517	916
Net cash used by operating activities	(7,368)	(5,726)
Investing activities:
Purchases of property and equipment	(448)	(106)
Deposits and other assets	35	16
Net cash used by investing activities	(413)	(90)
Financing activities:
Proceeds from the issuance of common stock and warrants	16,458
Proceeds from prom issuance of bridge loan, related party	1,300	300
Payments on convertible debenture	(4,363)
Proceeds from the issuance of senior promissory note, related party		5,505
Transactions costs	(1,667)
Capital lease obligations	(19)	(54)
Net cash provided by financing activities	11,709	5,751
Net increase (decrease) in cash and cash equivalents	3,928	(65)
Cash and cash equivalents at beginning of period	851	916
Cash and cash equivalents at end of period	4,779	851
Supplemental disclosure of cash paid
Interest	106	149
Income taxes	40	48
Supplemental disclosure of non-cash activity
Common stock issued for exercise of warrants		46
Common stock issued for conversion of debt and accrued interest	7,163
Property and equipment acquired through capital leases and other financing		34
Warrants Issued for Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants	252
Supplemental disclosure of non-cash activity
Issuance of stock and warrants	252
Common Stock Issued for Consulting Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants	181
Supplemental disclosure of non-cash activity
Issuance of stock and warrants	181
Common Stock Issued Upon Settlement of Deferred Compensation to Officer [Member]
Supplemental disclosure of non-cash activity
Common stock issued upon settlement of deferred compensation to officer	$ 1,122

Note 1 - Summary of Significant

Note 1 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 1. Description of Business We harness proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives. Our OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions. We have a unique ability to engage these members, who do not OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52 50 Basis of Consolidation, Presentation, and Liquidity A t December 31, 2017, $4.8 $7,000 We could continue to incur negative cash flows and operating losses for the next twelve $618,000 We expect our current cash resources to cover expenses through at least the next twelve Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management ’s plan to increase revenue and continue to control expenses. We currently operate our On Trak nineteen 2018. Management ’s Plans Historically we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. These conditions raise substantial d oubt about our ability to continue as a going concern. The accompanying financial statements do not Trak first 2018. 2018. December 31, 2017, twelve All inter-company transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, the evaluation of asset impairment, the valuation of warrant liabilities, and shared-based compensation. Actual results could differ from those estimates. Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis or an upfront case rate based on enrolled members . To the extent our contracts may may not twelve Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM Share-Based Compensation Our 2017 “2017 2,333,334 243,853 2010 “2010 422A 2017 no ten three five December 31, 2017, 1,885,383 691,804 2017 Share-based compensation expense attributable to continuing operations were $ 465,000 $697,000 December 31, 2017 2016, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black -Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. We recognize forfeitures when they occur. There were 1.7 for the year ended December 31, 2017 no December 31, 2016. The stock compensation expense was calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2017 Expected volatility 102.90% Risk-free interest rate 2.23 - 2.46% Weighted average expected lives in years 10.0 Expected dividend 0% Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and w arrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no not no twelve December 31, 2017 2016, Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740 no Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 3,896,911 1,557,369 December 31, 2017 2016, Cash and Cash Equivalents We consider all highly l iquid investments with an original maturity of three may December 31, 2017, $4.6 Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 market participant assumptions developed based on market data obtained from independent sources (observable inputs) and ( 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management ’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table s summarize fair value measurements by level at December 31, 2017 2016, Balance at December 31, 201 6 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 106 - - 106 Total assets 106 - - 106 Warrant liabilitie s - - 5,307 5,307 Derivative Liabilit y 8,122 8,122 Total liabilities - - 13,429 13,429 Balance at December 31, 201 7 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 71 - - 71 Total assets 71 - - 71 Warrant liabilitie s - - 30 30 Derivative Liabilit y - - Total liabilities - - 30 30 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2017, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein , for the years ended December 31, 2017 2016: Level II I Level II I Warrant Derivative (Dollars in thousands ) Liabilitie s (Dollars in thousands ) Liabilitie s Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Exchange of warrants 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance (exercise) of warrants, net 2,674 Issuance (exercise) of derivatives, net - Change in fair value (1,778 ) Change in fair value (132 ) Write off of warrants (6,173 ) Write off of derivative liability (7,990 ) Balance as of December 31, 2017 $ 30 Balance as of December 31, 2017 $ - Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven which is typically five seven Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840 Warrant Liabilities In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 75,000 $2.82 “March 2016 106,818 March 2016 $1.98 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 33,333 $2.82 “April 2016 47,475 April 2016 $1.98 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 51,136 $1.98 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 60,606 $1.98 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 71,970 $1.98 “July 2016 . In August 2016, three $2.8 “August 2016 five 145,833 $6.60 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 338,005 $1.98 498,927 $6.60 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 ( five ’s common stock in amount equal to forty 40% 337,139 $6.60 “December 2016 April 2017, The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 ( “December 2016 five ’s common stock in an amount equal to seventy-five 75% 44,118 December 2016 $5.10 March 2017, December 2016 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 December 31, 2017. In January 2017, $1,300,000 8% March 31, 2017 ( “January 2017 five one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 The January 2017 January 2017 January 2017 January 2017 January 2017 In connection with the Subscription Agreement described above, the number of Shamus warrants issued as part of the December 2016 75% 100% 14,706 In June 2017, 90,0000 $5.00 The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 201 7 December 31, 201 6 Expected volatility 102.90 % 104.31% Risk-free interest rate 1.89 % 1.20 - 1.93% Weighted average expected lives in years 2.29 2.25 - 4.99 Expected dividend 0 % 0% For the years ended December 31, 2017 2016, $1.8 $2.1 Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash and accounts receivable. All of our customers are based in the United States at this time and we are not The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no For the year ended December 31, 2017, four 90% four 96% For the year ended December 31, 201 6, two 78% two 81% Derivative Liability In July 2015, $3.55 12% January 18, 2016 “July 2015 July 2015 $11.40 may In October 2016, July 2015 January 18, 2016 January 18, 2017. July 2015 $1.80 July 2015 12% July 2015 April 30, 2017 April 2017, July 2015 2,385,111 Fo r the twelve December 31, 2017 2016, $132,000 $5.8 Recen tly Issued or Newly Adopted Accounting Pronouncements In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2016 10 2014 09, 2014 09, December 15, 2017. 2016 10 $1.8 January 1, 2018. In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718 2016 09” December 15, 2016, 2016 09 not In February 2015, Consolidation (Topic 810 2015 02” 2015 02 2015 02 December 15, 2015, 2015 02 not In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40 2014 15” . 2014 15 not may no one one not 2014 15 December 15, 2016. 2014 15 not

Note 2 - Accounts Receivable

Note 2 - Accounts Receivable	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 2 . Accounts Receivable Accounts receivables consisted of the following as of December 31, 2017 2016: December 31 , (in thousands ) 201 7 201 6 Healthcare fee s $ 985 $ 1,050 Othe r 2 2 Total receivable s $ 987 $ 1,052 Less allowance for doubtful account s (476 ) - Total receivables, ne t $ 511 $ 1,052 We use the specific identification method for recording the provision for doubtful accounts, which was $476 $0 December 31, 2017 2016.

Note 3 - Property and Equipment

Note 3 - Property and Equipment	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 3 . Property and Equipment Property and equipment consisted of the following as of December 31, 2017 2016: (in thousands ) 201 7 201 6 Furniture and equipmen t $ 1,836 $ 1,712 Leasehold improvement s 318 318 Total property and equipmen t 2,154 2,030 Less accumulated depreciation and amortizatio n (1,542 ) (1,620 ) Total property and equipment, ne t $ 612 $ 410 Depreciation expense was $246,000 $141,000 December 31, 2017 2016,

Note 4 - Capital Lease Obligati

Note 4 - Capital Lease Obligations	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Capital Leases in Financial Statements of Lessee Disclosure [Text Block]	Note 4 . Capital Lease Obligations We lease certain computer equipment under agreements entered into during 2016 $86,000 $103,000 December 31, 2017 2016, December 31, 2017 2016 $59,000 $47,000, The future minimum lease payments required under the capital leases and the present values of the net minimum lease payments as of December 31, 2017, (in thousands ) Amoun t Year ending December 31 , 201 8 $ 34 201 9 2 Total minimum lease payment s 36 Less amounts representing interes t (5 ) Capital lease obligations, net of interes t 31 Less current maturities of capital lease obligation s (29 ) Long-term capital lease obligation s $ 2

Note 5 - Income Taxes

Note 5 - Income Taxes	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 5 . Income Taxes As of December 31, 201 7, $235 $222 2025, 2017. seven The primary components of temporary differences which give rise to our net deferred tax assets are as follows: 201 7 201 6 (in thousands ) Federal, state and foreign net operating losse s $ 53,911 $ 78,466 Stock based compensatio n 4,937 7,429 Accrued liabilitie s 157 664 Other temporary difference s 3,426 4,894 Valuation allowanc e (62,431 ) (91,453 ) $ - $ - The Company has provided a valuation allowance in full on its net deferred tax assets in accordance with ASC 740 not 740. federal tax code, which could further limit the Company's ability to realize its deferred tax assets. A reconciliation between the statutory federal income tax rate and the effective income tax rate for the years ended December 31, 201 7 201 6 Federal statutory rat e -34.0 % -34.0 % State taxes, net of federal benefi t -5.5 % 26.2 % Non-deductible goodwil l 0.0 % 0.0 % ISO / ESP P 0.3 % 0.2 % Othe r 249.6 % -0.5 % Change in valuation allowanc e -210.4 % 8.0 % Tax provisio n 0.0 % -0.1 % Current accounting rules require that companies recognize in the consolidated financial statements the impact of a tax position, if that position is more likely than not 2012 2016. 2012. no December 31, 2017, no The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not not There were no December 31, 2017 2016, no 2011, 2012.

Note 6 - Common Stock

Note 6 - Common Stock	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 6 . Common Stock In April 2017, ’s securities. Pursuant to the underwriting agreement, we agreed to issue and sell an aggregate 3,125,000 $4.80 $4.464 April 28, 2017. $15.0 Pursuant to the underwriting agreement with Joseph Gunnar, we granted the underwriters a 45 468,750 May, 303,750 $1.5 In connection with the public offering, our common stock began trading on the NASDAQ Capital Market (“NASDAQ”) under the symbol “CATS” beginning on April 26, 2017. In April 2017, including Acuitas and Shamus exercised their option to convert their convertible debentures and received 2,982,994 $1.4 twelve December 31, 2017. In April 2017, $1.1 233,734 $83,807 In April 2017, 1 6 of our common stock, pursuant to which each six one not No All stock options and warrants to purchase common stock outstanding and our common stock reserved for issuance under our equity incentive plans immediately prior to the reverse stock split were appropriately adjusted by dividing the number of affected shares of common stock by six six During 2017 2016, 28,985 39,167 $181,000 $235,000,

Note 7 - Share-based Compensati

Note 7 - Share-based Compensation	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 7 . Share-based Compensation The 2017 provides for the issuance of up to 2,333,334 243,853 2010 422A 2017 We grant all such share-based compensation awards at no no ten three five December 31, 2017, 1,885,383 691,804 $465,000 $697,000 December 31, 2017 2016, Stock Options – Employees and Directors There were 1,674,864 2017 no 2016. The estimated weighted average fair value of the options granted during 2017 $2.32 Stock option activity for employee and director grants is summarized as follows: Weighted Avg. Aggregate Shares Exercise Price Intrinsic Value Balance, December 31, 2015 245,213 $ 39.06 $ - 2016 Granted - - Cancelled/Expired (1,167 ) 67.86 Balance, December 31, 2016 244,046 $ 38.94 $ - 2017 Granted 1,674,864 7.50 Cancelled/Expired (33,527 ) 14.54 Balance, December 31, 2017 1,885,383 $ 11.46 $ - Exercisable at December 31, 2017 306,612 $ 31.49 $ - The weighted average remaining contractual life and weighted average exercise price of options outstanding as of December 31, 2017 Options Outstandin g Options Exercisabl e Range of Exercise Price s Share s Weighted Average Remaining Life (yrs ) Weighted Average Pric e Share s Weighted Average Pric e $0.00 to $110.0 0 1,883,839 8.64 $ 10.66 305,068 $ 26.82 $110.01 to to $1,500.0 0 1,544 1.03 953.39 1,544 953.39 1,885,383 8.63 $ 11.43 306,612 $ 31.49 Share-based compensation expense relating to stock options granted to employees and directors was $465,000 $697,000 December 31, 2017 2016, As of December 31, 2017, $4.7 4.23 Stock Options and Warrants – Non-employees In addition to stock options granted under the Plan, we have also granted options and warrants to purchase our common stock to certain non-employees that have been approved by our Board of Directors. W arrants granted to non-employees outstanding as of December 31, 2017 2016, December 31, 201 7 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g 156,250 $ 6.00 Warrants issued in connection with debt agreement s 451,918 4.51 Warrants issued for service s 90,000 5.00 698,168 $ 4.91 December 31, 201 6 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g - $ - Warrants issued in connection with debt agreement s 1,026,017 4.80 Warrants issued for service s - - 1,026,017 $ 4.80

Note 8 - Commitments and Contin

Note 8 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 8 . Commitments and Contingencies Operating Lease Commitments We incurred rent expense of approximately $296,000 $296,000 December 31, 2017 2016, Our principal executive and administrative offices are located in Los Angeles, California and consist of leased office space totaling approximately 9,120 April 2019. $32,000 Rent expense is calculated using the straight-line method based on the total minimum lease payments over the initial term of the lease. Landlord tenant improvement allowances and rent expense exceeding actual rent payments are accounted for as deferred rent liability in the balance sheet and amortized on a straight- line basis over the initial term of the respective leases. Future minimum payments, by year and in the aggregate, under non-cancelable operating leases with initial or remaining terms of one December 31, 2017: (In thousands ) Yea r Amoun t 201 8 $ 387 201 9 $ 99 Legal Proceedings From time to time, we may not as of December 31, 2017.

Note 9 - Related Party Disclosu

Note 9 - Related Party Disclosure	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 9 . Related Party Disclosure In January 2017, $1.3 254,904 April 2017, $1.3 In January 2017, December 2016 75% 100% 137,883 In March 2017, July 2015 not .2 warrants to purchase 31,167 April 2017. In April 2017, 181,154 $869,539 In April 2017, July 2015 $4.3 2,385,111 In April 2017, December 2016 8% $2.9 In April 2017, $1.1 233,734 $83,807 In addition, we have accounts payable outstanding with Mr. Peizer for travel and expenses of approximately $2 54,000 December 31, 2017. In January 2017, December 2016 75% 100% 14,706 In March 2017, $1.3 December 2016 276,204

Note 10 - Short-term Debt

Note 10 - Short-term Debt	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 10 . Short -term Debt In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 75,000 $2.82 “March 2016 106,818 March 2016 $1.98 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 33,33 4 $2.82 “April 2016 47,475 April 2016 $1.98 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 51,136 $1.98 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 60,606 $1.98 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 71,970 $1.98 “July 2016 . In August 2016, three $2.8 “August 2016 five 145,833 $6.60 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 338,005 $1.98 498,927 $6.60 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 ( five ’s common stock in amount equal to forty 40% 337,139 $6.60 “December 2016 April 2017, The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 ( “December 2016 five ’s common stock in an amount equal to seventy-five 75% 44,118 December 2016 $5.10 March 2017, December 2016 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 December 31, 2017. In January 2017, $1,300,000 8% March 31, 2017 ( “January 2017 254,904 five ’s common stock which is equal to one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3

Note 11 - Restatement of Financ

Note 11 - Restatement of Financial Statements	12 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Accounting Changes and Error Corrections [Text Block]	Note 1 1 . Restatement of Financial Statements The prior year financial statements have been retroactively restated to reflect the 1 6 April 25, 2017.

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Basis of Consolidation, Presentation, and Liquidity A t December 31, 2017, $4.8 $7,000 We could continue to incur negative cash flows and operating losses for the next twelve $618,000 We expect our current cash resources to cover expenses through at least the next twelve Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management ’s plan to increase revenue and continue to control expenses. We currently operate our On Trak nineteen 2018. Management ’s Plans Historically we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. These conditions raise substantial d oubt about our ability to continue as a going concern. The accompanying financial statements do not Trak first 2018. 2018. December 31, 2017, twelve All inter-company transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, the evaluation of asset impairment, the valuation of warrant liabilities, and shared-based compensation. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis or an upfront case rate based on enrolled members . To the extent our contracts may may not twelve
Cost of Sales, Policy [Policy Text Block]	Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Share-Based Compensation Our 2017 “2017 2,333,334 243,853 2010 “2010 422A 2017 no ten three five December 31, 2017, 1,885,383 691,804 2017 Share-based compensation expense attributable to continuing operations were $ 465,000 $697,000 December 31, 2017 2016, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black -Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. We recognize forfeitures when they occur. There were 1.7 for the year ended December 31, 2017 no December 31, 2016. The stock compensation expense was calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2017 Expected volatility 102.90% Risk-free interest rate 2.23 - 2.46% Weighted average expected lives in years 10.0 Expected dividend 0% Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and w arrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no not no twelve December 31, 2017 2016,
Income Tax, Policy [Policy Text Block]	Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740 no
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 3,896,911 1,557,369 December 31, 2017 2016,
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents We consider all highly l iquid investments with an original maturity of three may December 31, 2017, $4.6
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 market participant assumptions developed based on market data obtained from independent sources (observable inputs) and ( 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management ’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table s summarize fair value measurements by level at December 31, 2017 2016, Balance at December 31, 201 6 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 106 - - 106 Total assets 106 - - 106 Warrant liabilitie s - - 5,307 5,307 Derivative Liabilit y 8,122 8,122 Total liabilities - - 13,429 13,429 Balance at December 31, 201 7 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 71 - - 71 Total assets 71 - - 71 Warrant liabilitie s - - 30 30 Derivative Liabilit y - - Total liabilities - - 30 30 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2017, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein , for the years ended December 31, 2017 2016: Level II I Level II I Warrant Derivative (Dollars in thousands ) Liabilitie s (Dollars in thousands ) Liabilitie s Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Exchange of warrants 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance (exercise) of warrants, net 2,674 Issuance (exercise) of derivatives, net - Change in fair value (1,778 ) Change in fair value (132 ) Write off of warrants (6,173 ) Write off of derivative liability (7,990 ) Balance as of December 31, 2017 $ 30 Balance as of December 31, 2017 $ -
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven which is typically five seven
Lessee, Leases [Policy Text Block]	Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840
Warrant Liabilities, Policy [Policy Text Block]	Warrant Liabilities In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 75,000 $2.82 “March 2016 106,818 March 2016 $1.98 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 33,333 $2.82 “April 2016 47,475 April 2016 $1.98 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 51,136 $1.98 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 60,606 $1.98 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 71,970 $1.98 “July 2016 . In August 2016, three $2.8 “August 2016 five 145,833 $6.60 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 338,005 $1.98 498,927 $6.60 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 ( five ’s common stock in amount equal to forty 40% 337,139 $6.60 “December 2016 April 2017, The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 ( “December 2016 five ’s common stock in an amount equal to seventy-five 75% 44,118 December 2016 $5.10 March 2017, December 2016 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. In March 2017, April 17, 2015 July 30, 2015 $5.3 December 31, 2016. not .2 11,049 not warrants to purchase 31,167 13,258 April 26, 2017. $6.2 December 31, 2017. In January 2017, $1,300,000 8% March 31, 2017 ( “January 2017 five one hundred 100% January 2017 $5.10 “January 2017 December 2016 25% 137,883 January 2017 April 30, 2017 April 2017, $1.3 The January 2017 January 2017 January 2017 January 2017 January 2017 In connection with the Subscription Agreement described above, the number of Shamus warrants issued as part of the December 2016 75% 100% 14,706 In June 2017, 90,0000 $5.00 The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 201 7 December 31, 201 6 Expected volatility 102.90 % 104.31% Risk-free interest rate 1.89 % 1.20 - 1.93% Weighted average expected lives in years 2.29 2.25 - 4.99 Expected dividend 0 % 0% For the years ended December 31, 2017 2016, $1.8 $2.1
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash and accounts receivable. All of our customers are based in the United States at this time and we are not The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no For the year ended December 31, 2017, four 90% four 96% For the year ended December 31, 201 6, two 78% two 81%
Derivatives, Policy [Policy Text Block]	Derivative Liability In July 2015, $3.55 12% January 18, 2016 “July 2015 July 2015 $11.40 may In October 2016, July 2015 January 18, 2016 January 18, 2017. July 2015 $1.80 July 2015 12% July 2015 April 30, 2017 April 2017, July 2015 2,385,111 Fo r the twelve December 31, 2017 2016, $132,000 $5.8
New Accounting Pronouncements, Policy [Policy Text Block]	Recen tly Issued or Newly Adopted Accounting Pronouncements In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2016 10 2014 09, 2014 09, December 15, 2017. 2016 10 $1.8 January 1, 2018. In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718 2016 09” December 15, 2016, 2016 09 not In February 2015, Consolidation (Topic 810 2015 02” 2015 02 2015 02 December 15, 2015, 2015 02 not In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40 2014 15” . 2014 15 not may no one one not 2014 15 December 15, 2016. 2014 15 not

Note 1 - Summary of Significa21

Note 1 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	December 31, 2017 Expected volatility 102.90% Risk-free interest rate 2.23 - 2.46% Weighted average expected lives in years 10.0 Expected dividend 0%
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Balance at December 31, 201 6 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 106 - - 106 Total assets 106 - - 106 Warrant liabilitie s - - 5,307 5,307 Derivative Liabilit y 8,122 8,122 Total liabilities - - 13,429 13,429 Balance at December 31, 201 7 (Amounts in thousands ) Level I Level I I Level II I Tota l Certificates of deposi t 71 - - 71 Total assets 71 - - 71 Warrant liabilitie s - - 30 30 Derivative Liabilit y - - Total liabilities - - 30 30
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Level II I Level II I Warrant Derivative (Dollars in thousands ) Liabilitie s (Dollars in thousands ) Liabilitie s Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Exchange of warrants 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Issuance (exercise) of warrants, net 2,674 Issuance (exercise) of derivatives, net - Change in fair value (1,778 ) Change in fair value (132 ) Write off of warrants (6,173 ) Write off of derivative liability (7,990 ) Balance as of December 31, 2017 $ 30 Balance as of December 31, 2017 $ -
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	December 31, 201 7 December 31, 201 6 Expected volatility 102.90 % 104.31% Risk-free interest rate 1.89 % 1.20 - 1.93% Weighted average expected lives in years 2.29 2.25 - 4.99 Expected dividend 0 % 0%

Note 2 - Accounts Receivable (T

Note 2 - Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	December 31 , (in thousands ) 201 7 201 6 Healthcare fee s $ 985 $ 1,050 Othe r 2 2 Total receivable s $ 987 $ 1,052 Less allowance for doubtful account s (476 ) - Total receivables, ne t $ 511 $ 1,052

Note 3 - Property and Equipme23

Note 3 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	(in thousands ) 201 7 201 6 Furniture and equipmen t $ 1,836 $ 1,712 Leasehold improvement s 318 318 Total property and equipmen t 2,154 2,030 Less accumulated depreciation and amortizatio n (1,542 ) (1,620 ) Total property and equipment, ne t $ 612 $ 410

Note 4 - Capital Lease Obliga24

Note 4 - Capital Lease Obligations (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]	(in thousands ) Amoun t Year ending December 31 , 201 8 $ 34 201 9 2 Total minimum lease payment s 36 Less amounts representing interes t (5 ) Capital lease obligations, net of interes t 31 Less current maturities of capital lease obligation s (29 ) Long-term capital lease obligation s $ 2

Note 5 - Income Taxes (Tables)

Note 5 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	201 7 201 6 (in thousands ) Federal, state and foreign net operating losse s $ 53,911 $ 78,466 Stock based compensatio n 4,937 7,429 Accrued liabilitie s 157 664 Other temporary difference s 3,426 4,894 Valuation allowanc e (62,431 ) (91,453 ) $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	201 7 201 6 Federal statutory rat e -34.0 % -34.0 % State taxes, net of federal benefi t -5.5 % 26.2 % Non-deductible goodwil l 0.0 % 0.0 % ISO / ESP P 0.3 % 0.2 % Othe r 249.6 % -0.5 % Change in valuation allowanc e -210.4 % 8.0 % Tax provisio n 0.0 % -0.1 %

Note 7 - Share-based Compensa26

Note 7 - Share-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Options Outstandin g Options Exercisabl e Range of Exercise Price s Share s Weighted Average Remaining Life (yrs ) Weighted Average Pric e Share s Weighted Average Pric e $0.00 to $110.0 0 1,883,839 8.64 $ 10.66 305,068 $ 26.82 $110.01 to to $1,500.0 0 1,544 1.03 953.39 1,544 953.39 1,885,383 8.63 $ 11.43 306,612 $ 31.49
Schedule of Other Share-based Compensation, Activity [Table Text Block]	December 31, 201 7 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g 156,250 $ 6.00 Warrants issued in connection with debt agreement s 451,918 4.51 Warrants issued for service s 90,000 5.00 698,168 $ 4.91 December 31, 201 6 Descriptio n Share s Weighted Average Exercise Pric e Warrants issued in connection with equity offerin g - $ - Warrants issued in connection with debt agreement s 1,026,017 4.80 Warrants issued for service s - - 1,026,017 $ 4.80
Employees and Directors [Member]
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Avg. Aggregate Shares Exercise Price Intrinsic Value Balance, December 31, 2015 245,213 $ 39.06 $ - 2016 Granted - - Cancelled/Expired (1,167 ) 67.86 Balance, December 31, 2016 244,046 $ 38.94 $ - 2017 Granted 1,674,864 7.50 Cancelled/Expired (33,527 ) 14.54 Balance, December 31, 2017 1,885,383 $ 11.46 $ - Exercisable at December 31, 2017 306,612 $ 31.49 $ -

Note 8 - Commitments and Cont27

Note 8 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	(In thousands ) Yea r Amoun t 201 8 $ 387 201 9 $ 99

Note 1 - Summary of Significa28

Note 1 - Summary of Significant Accounting Policies (Details Textual)	Jan. 01, 2018USD ($)	Jun. 30, 2017$ / sharesshares	Apr. 30, 2017USD ($)shares	Jan. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Aug. 31, 2016USD ($)$ / sharesshares	Jul. 31, 2016USD ($)$ / sharesshares	Jun. 30, 2016USD ($)$ / sharesshares	May 31, 2016USD ($)$ / sharesshares	Apr. 30, 2016USD ($)$ / sharesshares	Mar. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)$ / sharesshares	Mar. 31, 2017shares	Oct. 31, 2016$ / shares	Dec. 31, 2015USD ($)	Jul. 31, 2015USD ($)$ / shares
Cash and Cash Equivalents, at Carrying Value					$ 851,000							$ 4,779,000	$ 851,000			$ 916,000
Working Capital Deficit												7,000,000,000
Cash Burn Rate												618,000
Share-based Compensation												$ 465,000	$ 697,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares												1,700,000	0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares												3,896,911	1,557,369
Cash, Uninsured Amount												$ 4,600,000
Proceeds from Related Party Debt													$ 5,505,000
Warrant Liabilities, Noncurrent					5,307,000							30,000	5,307,000
Repayments of Convertible Debt												4,363,000
Fair Value Adjustment of Warrants												(1,778,000)	(2,093,000)
Derivative, Gain (Loss) on Derivative, Net												$ 132,000	$ (5,800,000)
Accounting Standards Update 2016-10 [Member] | Subsequent Event [Member]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Revenue	$ 1,800,000
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Number of Major Customers												4	2
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Four Customers [Member]
Concentration Risk, Percentage												90.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk, Percentage													78.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Number of Major Customers												4	2
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Customers [Member]
Concentration Risk, Percentage												96.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk, Percentage													81.00%
Amended Warrants [Member]
Warrant Liabilities, Noncurrent					5,300,000								$ 5,300,000
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right | shares														0.2
Write-off of Warrant Liability												$ 6,200,000
Warrants Not Subject to Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares														11,049
Warrants Issued for Services [Member]
Class of Warrant or Right, Issued During Period | shares		90,000
Warrants Issued Weighted Average Exercise Price | $ / shares		$ 5
Director [Member]
Warrant Term						5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						145,833
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 6.60
Proceeds from Related Party Debt						$ 2,800,000
Investors [Member]
Debt Instrument, Face Amount					$ 5,600,000								$ 5,600,000
Investors [Member] | December 2016 Warrants [Member]
Warrant Term					5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 6.60								$ 6.60
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion					40.00%								40.00%
Class of Warrant or Right, Issued During Period | shares					337,139								337,139
Shamus [Member] | Shamus Warrants [Member]
Warrant Term					5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				14,706
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 5.10								$ 5.10
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion				100.00%	75.00%								75.00%
Class of Warrant or Right, Issued During Period | shares					44,118
Acuitas [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				137,883
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion					25.00%								25.00%
Class of Warrant or Right, Additional Percent of Securities Called by Warrants or Rights Upon Conversion				25.00%
Acuitas [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares														31,167
Acuitas [Member] | January 2017 Warrants [Member]
Warrant Term				5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 5.10
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion				100.00%
Acuitas [Member] | July 2015 Convertible Debenture [Member]
Debt Instrument, Interest Rate, Stated Percentage																	12.00%
Debt Instrument, Face Amount																	$ 3,550,000
Debt Instrument, Convertible, Conversion Price | $ / shares															$ 1.80		$ 11.40
Debt Conversion, Converted Instrument, Shares Issued | shares			2,385,111
Acuitas [Member]
Warrant Term							5 years	5 years	5 years	5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						338,005	71,970	60,606	51,136	33,333	75,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 1.98	$ 1.98	$ 1.98	$ 1.98	$ 2.82	$ 2.82
Class of Warrant or Right, Outstanding | shares										47,475	106,818
Acuitas [Member] | Exchange of Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						498,927
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 6.60
Accredited Investor [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares														13,258
April 2016 Promissory Note [Member] | Acuitas [Member]
Proceeds from Issuance of Debt										$ 400,000
Debt Instrument, Face Amount										1,300,000
May 2016 Promissory Note [Member] | Acuitas [Member]
Proceeds from Issuance of Debt									$ 405,000
Debt Instrument, Face Amount									1,700,000
June 2016 Promissory Notes [Member] | Acuitas [Member]
Proceeds from Issuance of Debt							$ 570,000	$ 480,000
Debt Instrument, Face Amount							2,800,000	2,200,000
Senior Promissory Note [Member] | Acuitas [Member] | Exchanged Senior Demand Notes [Member]
Debt Instrument, Face Amount					$ 2,800,000	$ 2,800,000							$ 2,800,000
Debentures [Member] | Investors [Member]
Debt Instrument, Interest Rate, Stated Percentage					8.00%	8.00%							8.00%
Warrant Term					5 years
Debt Instrument, Face Amount						$ 5,600,000
Debentures [Member] | Shamus [Member]
Warrant Term													5 years
December 2016 Convertible Debenture [Member] | Investors [Member]
Debt Instrument, Interest Rate, Stated Percentage			8.00%
Repayments of Convertible Debt			$ 2,900,000
December 2016 Convertible Debenture [Member] | Shamus [Member]
Proceeds from Issuance of Debt					$ 300,000								$ 300,000
Debt Instrument, Interest Rate, Stated Percentage					8.00%								8.00%
January 2017 Convertible Debenture [Member] | Acuitas [Member]
Proceeds from Issuance of Debt				$ 1,300,000
Debt Instrument, Interest Rate, Stated Percentage				8.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				254,904
Class of Warrant or Right, Issued During Period | shares				254,904
Repayments of Convertible Debt			$ 1,300,000
Acuitas [Member] | March 2016 Promissory Note [Member]
Proceeds from Issuance of Debt											$ 900,000
Debt Instrument, Term											30 days
Debt Instrument, Interest Rate, Stated Percentage											8.00%
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date											12.00%
Debt Instrument, Face Amount											$ 900,000
Acuitas [Member] | April 2016 Promissory Note [Member]
Proceeds from Issuance of Debt										400,000
Debt Instrument, Face Amount										$ 1,300,000
Acuitas [Member] | May 2016 Promissory Note [Member]
Proceeds from Issuance of Debt									405,000
Debt Instrument, Face Amount									$ 1,700,000
Acuitas [Member] | June 2016 Promissory Notes [Member]
Proceeds from Issuance of Debt							570,000	480,000
Short-term Debt							$ 2,800,000	$ 2,200,000
Minimum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life												2 years
Minimum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life												5 years
Maximum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life												7 years
Maximum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life												7 years
The 2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares												2,333,334
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period												10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares												1,885,383
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares												691,804
Share-based Compensation												$ 465,000	$ 697,000
The 2017 Stock Incentive Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period												3 years
The 2017 Stock Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period												5 years
The 2010 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares												243,853

Note 1 - Summary of Significa29

Note 1 - Summary of Significant Accounting Policies - Fair Value Assumptions, Stock Options (Details) - Employee Stock Option [Member]	12 Months Ended
	Dec. 31, 2017
Expected volatility	102.90%
Weighted average expected lives in years (Year)	10 years
Expected dividend	0.00%
Minimum [Member]
Risk-free interest rate	2.23%
Maximum [Member]
Risk-free interest rate	2.46%

Note 1 - Summary of Significa30

Note 1 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Total assets	$ 71	$ 106
Warrant liabilities	30	5,307
Derivative Liability		8,122
Total liabilities	30	13,429
Certificates of Deposit [Member]
Certificates of deposit	71	106
Fair Value, Inputs, Level 1 [Member]
Total assets	71	106
Warrant liabilities
Derivative Liability
Total liabilities
Fair Value, Inputs, Level 1 [Member] | Certificates of Deposit [Member]
Certificates of deposit	71	106
Fair Value, Inputs, Level 2 [Member]
Total assets
Warrant liabilities
Derivative Liability
Total liabilities
Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member]
Certificates of deposit
Fair Value, Inputs, Level 3 [Member]
Total assets
Warrant liabilities	30	5,307
Derivative Liability		8,122
Total liabilities	30	13,429
Fair Value, Inputs, Level 3 [Member] | Certificates of Deposit [Member]
Certificates of deposit

Note 1 - Summary of Significa31

Note 1 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Warrants [Member]
Balance	$ 5,307	$ 509
Issuance (exercise) of warrants, net	2,674	4,821
Change in fair value	(1,778)	(2,093)
Exchange of warrants		2,070
Write off of warrants	(6,173)
Balance	30	5,307
Derivative Financial Instruments, Liabilities [Member]
Balance	8,122	2,348
Issuance (exercise) of warrants, net
Change in fair value	(132)	5,774
Exchange of warrants
Write off of warrants	(7,990)
Balance		$ 8,122

Note 1 - Summary of Significa32

Note 1 - Summary of Significant Accounting Policies - Fair Value Assumptions, Warrant Liabilities (Details) - Warrant Liability [Member]	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Expected volatility	102.90%	104.31%
Risk-free interest rate	1.89%
Weighted average expected lives in years (Year)	2 years 105 days
Expected dividend	0.00%	0.00%
Minimum [Member]
Risk-free interest rate		1.20%
Weighted average expected lives in years (Year)		2 years 91 days
Maximum [Member]
Risk-free interest rate		1.93%
Weighted average expected lives in years (Year)		4 years 361 days

Note 2 - Accounts Receivable (D

Note 2 - Accounts Receivable (Details Textual) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Allowance for Doubtful Accounts Receivable	$ 476,000	$ 0

Note 2 - Accounts Receivable -

Note 2 - Accounts Receivable - Summary of Accounts Receivables (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Receivables gross	$ 987,000	$ 1,052,000
Less allowance for doubtful accounts	(476,000)	0
Total receivables, net	511,000	1,052,000
Healthcare Fees [Member]
Receivables gross	985,000	1,050,000
Other Receivable [Member]
Receivables gross	$ 2,000	$ 2,000

Note 3 - Property and Equipme35

Note 3 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Depreciation	$ 246,000	$ 141,000

Note 3 - Property and Equipme36

Note 3 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Furniture and equipment	$ 1,836	$ 1,712
Leasehold improvements	318	318
Total property and equipment	2,154	2,030
Less accumulated depreciation and amortization	(1,542)	(1,620)
Total property and equipment, net	$ 612	$ 410

Note 4 - Capital Lease Obliga37

Note 4 - Capital Lease Obligations (Details Textual) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Property, Plant, and Equipment Other, Accumulated Depreciation	$ 59,000	$ 47,000
Furniture and Equipment [Member]
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Other Property, Plant, and Equipment, Gross	$ 86,000	$ 103,000

Note 4 - Capital Lease Obliga38

Note 4 - Capital Lease Obligations - Future Minimum Lease Payments Required Under the Capital Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
2,018	$ 34
2,019	2
Total minimum lease payments	36
Less amounts representing interest	(5)
Capital lease obligations, net of interest	31
Less current maturities of capital lease obligations	(29)
Long-term capital lease obligations	$ 2	$ 31

Note 5 - Income Taxes (Details

Note 5 - Income Taxes (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	$ 0	$ 0
Earliest Tax Year [Member]
Open Tax Year	2,012
Latest Tax Year [Member]
Open Tax Year	2,016
Domestic Tax Authority [Member]
Operating Loss Carryforwards	$ 235,000
State and Local Jurisdiction [Member]
Operating Loss Carryforwards	$ 222,000

Note 5 - Income Taxes - Primary

Note 5 - Income Taxes - Primary Components of Net Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Federal, state and foreign net operating losses	$ 53,911	$ 78,466
Stock based compensation	4,937	7,429
Accrued liabilities	157	664
Other temporary differences	3,426	4,894
Valuation allowance	$ (62,431)	$ (91,453)

Note 5 - Income Taxes - Reconci

Note 5 - Income Taxes - Reconciliation Between the Statutory Federal Income Tax Rate and the Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Federal statutory rate	(34.00%)	(34.00%)
State taxes, net of federal benefit	(5.50%)	26.20%
Non-deductible goodwill	0.00%	0.00%
ISO / ESPP	0.30%	0.20%
Other	249.60%	(0.50%)
Change in valuation allowance	(210.40%)	8.00%
Tax provision	0.00%	(0.10%)

Note 6 - Common Stock (Details

Note 6 - Common Stock (Details Textual)	Apr. 28, 2017USD ($)$ / sharesshares	Apr. 25, 2017	May 31, 2017USD ($)shares	Apr. 30, 2017USD ($)shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)shares
Proceeds from Issuance of Common Stock					$ 16,458,000
Gain (Loss) on Conversion of Debt					(1,356,000)
Gain (Loss) on Issuance of Common Stock					(145,000)
Stock Issued During Period, Value, Issued for Services					$ 181,000	$ 235,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues | shares					3,428,750
Stock Issued During Period, Shares, Issued for Services | shares					28,985	39,167
Stock Issued During Period, Value, Issued for Services					$ 181,000	$ 235,000
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio		6			6
Chairman and Chief Executive Officer [Member]
Deferred Salary Settled by Shares				$ 1,100,000
Common Stock Issued for Settlement of Deferred Salary Balance | shares				233,734
Gain (Loss) on Issuance of Common Stock				$ (83,807)
Several Investors, Including Acuitas and Shamus [Member] | Convertible Debentures [Member]
Debt Conversion, Converted Instrument, Shares Issued | shares				2,982,994
Gain (Loss) on Conversion of Debt					$ (1,400,000)
Public Offering [Member] | Joseph Gunnar & Co., LLC [Member]
Stock Issued During Period, Shares, New Issues | shares	3,125,000
Shares Issued, Price Per Share | $ / shares	$ 4.80
Shares Issued, Price Per Share, Net | $ / shares	$ 4.464
Proceeds from Issuance of Common Stock	$ 15,000,000
Over-Allotment Option [Member] | Joseph Gunnar & Co., LLC [Member]
Stock Issued During Period, Shares, New Issues | shares			303,750
Proceeds from Issuance of Common Stock			$ 1,500,000
Additional Shares Available for Purchase | shares	468,750

Note 7 - Share-based Compensa43

Note 7 - Share-based Compensation (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation	$ 465,000	$ 697,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,700,000	0
Employees and Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,674,864
The 2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	2,333,334
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	1,885,383
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	691,804
Share-based Compensation	$ 465,000	$ 697,000
The 2017 Stock Incentive Plan [Member] | Employees and Directors [Member]
Share-based Compensation	$ 465,000	$ 697,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,674,864	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 2.32
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 4,700,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	4 years 83 days
The 2017 Stock Incentive Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
The 2017 Stock Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	5 years
The 2010 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	243,853

Note 7 - Share-based Compensa44

Note 7 - Share-based Compensation - Employee and Director Stock Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Granted, shares (in shares)	1,700,000	0
Balance, shares (in shares)	1,885,383
Balance, weighted average exercise price (in dollars per share)	$ 11.43
Exercisable, shares (in shares)	306,612
Exercisable, weighted average exercise price (in dollars per share)	$ 31.49
Employees and Directors [Member]
Balance, shares (in shares)	244,046	245,213
Balance, weighted average exercise price (in dollars per share)	$ 38.94	$ 39.06
Granted, shares (in shares)	1,674,864
Granted, weighted average exercise price (in dollars per share)	$ 7.50
Cancelled/Expired, shares (in shares)	(33,527)	(1,167)
Cancelled/Expired, weighted average exercise price (in dollars per share)	$ 14.54	$ 67.86
Balance, shares (in shares)	1,885,383	244,046
Balance, weighted average exercise price (in dollars per share)	$ 11.46	$ 38.94
Exercisable, shares (in shares)	306,612
Exercisable, weighted average exercise price (in dollars per share)	$ 31.49

Note 7 - Share-based Compensa45

Note 7 - Share-based Compensation - Options by Exercise Price Range (Details)	12 Months Ended
	Dec. 31, 2017$ / sharesshares
Options Outstanding Shares (in shares) | shares	1,885,383
Options Outstanding Weighted Average Remaining Life (Year)	8 years 229 days
Options Outstanding Weighted Average Price (in dollars per share)	$ 11.43
Exercisable, shares (in shares) | shares	306,612
Exercisable, weighted average exercise price (in dollars per share)	$ 31.49
Range One [Member]
Lower Exercise Price Limit (in dollars per share)	0
Upper Exercise Price Limit (in dollars per share)	$ 110
Options Outstanding Shares (in shares) | shares	1,883,839
Options Outstanding Weighted Average Remaining Life (Year)	8 years 233 days
Options Outstanding Weighted Average Price (in dollars per share)	$ 10.66
Exercisable, shares (in shares) | shares	305,068
Exercisable, weighted average exercise price (in dollars per share)	$ 26.82
Range Two [Member]
Lower Exercise Price Limit (in dollars per share)	110.01
Upper Exercise Price Limit (in dollars per share)	$ 1,500
Options Outstanding Shares (in shares) | shares	1,544
Options Outstanding Weighted Average Remaining Life (Year)	1 year 10 days
Options Outstanding Weighted Average Price (in dollars per share)	$ 953.39
Exercisable, shares (in shares) | shares	1,544
Exercisable, weighted average exercise price (in dollars per share)	$ 953.39

Note 7 - Share-based Compensa46

Note 7 - Share-based Compensation - Stock Options and Warrants Granted to Non-employees for Services Outstanding (Details) - $ / shares	1 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2017	Dec. 31, 2016
Stock Options and Warrants Nonemployees [Member]
Warrants Issued (in shares)		698,168	1,026,017
Warrants Issued Weighted Average Exercise Price (in dollars per share)		$ 4.91	$ 4.80
Issued in Connection With Equity Offering [Member] | Stock Options and Warrants Nonemployees [Member]
Warrants Issued (in shares)		156,250
Warrants Issued Weighted Average Exercise Price (in dollars per share)		$ 6
Issued in Connection With Debt Agreement [Member] | Stock Options and Warrants Nonemployees [Member]
Warrants Issued (in shares)		451,918	1,026,017
Warrants Issued Weighted Average Exercise Price (in dollars per share)		$ 4.51	$ 4.80
Warrants Issued for Services [Member]
Warrants Issued (in shares)	90,000
Warrants Issued Weighted Average Exercise Price (in dollars per share)	$ 5
Warrants Issued for Services [Member] | Stock Options and Warrants Nonemployees [Member]
Warrants Issued (in shares)		90,000
Warrants Issued Weighted Average Exercise Price (in dollars per share)		$ 5

Note 8 - Commitments and Cont47

Note 8 - Commitments and Contingencies (Details Textual)	12 Months Ended
	Dec. 31, 2017USD ($)ft²	Dec. 31, 2016USD ($)
Operating Leases, Rent Expense, Net	$ 296,000	$ 296,000
Principal Executive and Administrative Offices [Member]
Area of Real Estate Property | ft²	9,120
Operating Lease Monthly Rent	$ 32,000

Note 8 - Commitments and Cont48

Note 8 - Commitments and Contingencies - Future Minimum Payments, Under Non-cancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2017USD ($)
2,018	$ 387
2,019	$ 99

Note 9 - Related Party Disclo49

Note 9 - Related Party Disclosure (Details Textual) - USD ($)	1 Months Ended				12 Months Ended
	Apr. 30, 2017	Mar. 31, 2017	Jan. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Jul. 31, 2015
Repayments of Convertible Debt					$ 4,363,000
Proceeds from Issuance of Common Stock					16,458,000
Gain (Loss) on Issuance of Common Stock					(145,000)
Due to Related Parties, Current				$ 9,796,000		$ 9,796,000
Amended Warrants [Member]
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right		0.2
Acuitas [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	31,167
Acuitas [Member] | July 2015 Convertible Debenture [Member]
Debt Conversion, Original Debt, Amount	$ 4,300,000
Debt Conversion, Converted Instrument, Shares Issued	2,385,111
Debt Instrument, Interest Rate, Stated Percentage							12.00%
Acuitas [Member] | Public Offering [Member]
Stock Issued During Period, Shares, New Issues	181,154
Proceeds from Issuance of Common Stock	$ 869,539
Acuitas [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		31,167
Acuitas [Member] | January 2017 Convertible Debenture [Member]
Proceeds from Issuance of Debt			$ 1,300,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			254,904
Repayments of Convertible Debt	1,300,000
Debt Instrument, Interest Rate, Stated Percentage			8.00%
Chairman and Chief Executive Officer [Member]
Deferred Salary Settled by Shares	$ 1,100,000
Common Stock Issued for Settlement of Deferred Salary Balance	233,734
Gain (Loss) on Issuance of Common Stock	$ (83,807)
Chairman and Chief Executive Officer [Member] | Travel and Expenses [Member]
Due to Related Parties, Current					$ 254,000
Chairman and Chief Executive Officer [Member] | Acuitas [Member]
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion			100.00%	75.00%		75.00%
Shamus [Member] | Conversion Of December 2016 Convertible Debentures Into Common Stock [Member]
Debt Conversion, Original Debt, Amount		$ 1,300,000
Debt Conversion, Converted Instrument, Shares Issued		276,204
Shamus [Member] | Shamus Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			14,706
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion			100.00%	75.00%		75.00%
Shamus [Member] | Acuitas [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			137,883
Shamus [Member] | December 2016 Convertible Debenture [Member]
Proceeds from Issuance of Debt				$ 300,000		$ 300,000
Debt Instrument, Interest Rate, Stated Percentage				8.00%		8.00%
Investors [Member] | December 2016 Convertible Debenture [Member]
Repayments of Convertible Debt	$ 2,900,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%

Note 10 - Short-term Debt (Deta

Note 10 - Short-term Debt (Details Textual) - USD ($)	1 Months Ended									12 Months Ended
	Apr. 30, 2017	Jan. 31, 2017	Dec. 31, 2016	Aug. 31, 2016	Jul. 31, 2016	Jun. 30, 2016	May 31, 2016	Apr. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2017
Proceeds from Related Party Debt											$ 5,505,000
Warrant Liabilities, Noncurrent			$ 5,307,000							30,000	5,307,000
Repayments of Convertible Debt										4,363,000
Amended Warrants [Member]
Warrant Liabilities, Noncurrent			5,300,000								5,300,000
Class of Warrant or Right, Number of Additional Securities Called by Each Warrant or Right												0.2
Write-off of Warrant Liability										$ 6,200,000
Warrants Not Subject to Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights												11,049
Director [Member]
Warrant Term				5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				145,833
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 6.60
Proceeds from Related Party Debt				$ 2,800,000
Investors [Member]
Debt Instrument, Face Amount			$ 5,600,000								$ 5,600,000
Investors [Member] | December 2016 Warrants [Member]
Warrant Term			5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 6.60								$ 6.60
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion			40.00%								40.00%
Class of Warrant or Right, Issued During Period			337,139								337,139
Shamus [Member] | Shamus Warrants [Member]
Warrant Term			5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		14,706
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 5.10								$ 5.10
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion		100.00%	75.00%								75.00%
Class of Warrant or Right, Issued During Period			44,118
Acuitas [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		137,883
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion			25.00%								25.00%
Acuitas [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights												31,167
Acuitas [Member] | January 2017 Warrants [Member]
Warrant Term		5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 5.10
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion		100.00%
Acuitas [Member]
Warrant Term					5 years	5 years	5 years	5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				338,005	71,970	60,606	51,136	33,333	75,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 1.98	$ 1.98	$ 1.98	$ 1.98	$ 2.82	$ 2.82
Class of Warrant or Right, Outstanding								47,475	106,818
Acuitas [Member] | Exchange of Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				498,927
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 6.60
Accredited Investor [Member] | Amended Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights												13,258
April 2016 Promissory Note [Member] | Acuitas [Member]
Proceeds from Issuance of Debt								$ 400,000
Debt Instrument, Face Amount								1,300,000
May 2016 Promissory Note [Member] | Acuitas [Member]
Proceeds from Issuance of Debt							$ 405,000
Debt Instrument, Face Amount							1,700,000
June 2016 Promissory Notes [Member] | Acuitas [Member]
Proceeds from Issuance of Debt					$ 570,000	$ 480,000
Debt Instrument, Face Amount					2,800,000	2,200,000
Senior Promissory Note [Member] | Acuitas [Member] | Exchanged Senior Demand Notes [Member]
Debt Instrument, Face Amount			$ 2,800,000	$ 2,800,000							$ 2,800,000
Debentures [Member] | Investors [Member]
Debt Instrument, Face Amount				$ 5,600,000
Debt Instrument, Interest Rate, Stated Percentage			8.00%	8.00%							8.00%
Warrant Term			5 years
Debentures [Member] | Shamus [Member]
Warrant Term											5 years
December 2016 Convertible Debenture [Member] | Investors [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Repayments of Convertible Debt	$ 2,900,000
December 2016 Convertible Debenture [Member] | Shamus [Member]
Proceeds from Issuance of Debt			$ 300,000								$ 300,000
Debt Instrument, Interest Rate, Stated Percentage			8.00%								8.00%
January 2017 Convertible Debenture [Member] | Acuitas [Member]
Proceeds from Issuance of Debt		$ 1,300,000
Debt Instrument, Interest Rate, Stated Percentage		8.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		254,904
Class of Warrant or Right, Issued During Period		254,904
Repayments of Convertible Debt	$ 1,300,000
Acuitas [Member] | March 2016 Promissory Note [Member]
Proceeds from Issuance of Debt									$ 900,000
Debt Instrument, Face Amount									$ 900,000
Debt Instrument, Term									30 days
Debt Instrument, Interest Rate, Stated Percentage									8.00%
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date									12.00%
Acuitas [Member] | April 2016 Promissory Note [Member]
Proceeds from Issuance of Debt								400,000
Debt Instrument, Face Amount								$ 1,300,000
Acuitas [Member] | May 2016 Promissory Note [Member]
Proceeds from Issuance of Debt							405,000
Debt Instrument, Face Amount							$ 1,700,000
Acuitas [Member] | June 2016 Promissory Notes [Member]
Proceeds from Issuance of Debt					$ 570,000	$ 480,000

Note 11 - Restatement of Fina51

Note 11 - Restatement of Financial Statements (Details Textual)	Apr. 25, 2017	Dec. 31, 2017
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	6	6